Mundipharma leaving the market
Mundipharma have advised that they are leaving the Aotearoa New Zealand market.
What Pharmac is doing
Pharmac is considering multiple options for products currently supplied by Mundipharma. We're reviewing each medicine to find the best solution. One option is using our annual tender process to find new suppliers for these treatments. We are updating this page with information about what is happening with each product.
We are working closely with Mundipharma and other suppliers to ensure as little disruption as possible for people using Mundipharma's products.
Products we're still seeking a resolution for
Chemical name | Stock available until | Presentation | Brand | Pharmacode |
---|---|---|---|---|
Dihydrocodeine tartrate | June 2025 | Tab long-acting 60 mg | DHC Continus | 772887 |
Oxycodone hydrochloride | June 2024 | cap 5 mg Immediate release | OxyNorm | 2179741 |
Oxycodone hydrochloride | June 2024 | cap 10 mg immediate release | OxyNorm | 2179768 |
Oxycodone hydrochloride | June 2024 | cap 20 mg immediate release | OxyNorm | 2179776 |
Oxycodone hydrochloride | June 2024 | oral liq 5 mg per 5 ml | OxyNorm | 2243687 |
Morphine sulphate | June 2025 | Tab immediate-release 10 mg | Sevredol | 2520990 |
Morphine sulphate | June 2025 | Tab immediate-release 20 mg | Sevredol | 2521008 |
Items being delisted
Chemical name | Presentation | Brand | Pharmacode | Resolution |
---|---|---|---|---|
Timolol | Eye drops 0.5%, gel forming | Timoptol XE | 204374 |
Restricted to no new patients 1 April 2023. To be delisted 1 March 2024 |
Dorzolamide hydrochloride | Eye drops 2% | Trusopt | 285226 |
Restricted to no new patients 1 April 2023. To be delisted 1 March 2024 |
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)